Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
about
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsIntegrated therapy for HIV and tuberculosisDiagnosis & treatment of tuberculosis in HIV co-infected patients.Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisHIV and Tuberculosis: a Deadly Human SyndemicDurability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study.Effect of pulmonary tuberculosis on mortality in patients receiving HAART.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusTuberculosis as part of the natural history of HIV infection in developing countriesInitiating antiretrovirals during tuberculosis treatment: a drug safety review.CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South IndiaNevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study.HIV-related liver disease: ARV drugs, coinfection, and other risk factors.Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin.Management of individuals requiring antiretroviral therapy and TB treatment.Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patientsTuberculosis and HIV co-infection: screening and treatment strategies.Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
P2860
Q24235724-9ECD57CD-4096-42BE-97A0-351F8B5EA4D6Q26749428-0E641125-EEF3-48DA-8547-B23A9B94EAC5Q26991633-4135D8CC-5B8F-4557-A5D9-C298FC893F88Q27021762-094F1408-CC8D-45F9-928E-6CDD8B2C5968Q30052157-6A9BD145-8C4B-49A8-BA97-09B63F58D482Q33375532-C76E056B-3952-4E1E-A2B4-585B41A2D5CBQ33764880-0D0E1AA6-3DAB-41B5-B37B-C019B3657B88Q34083071-9E77D2DD-3DFE-487C-942C-6CF9114135B5Q34547644-1971BC83-3C73-4F83-BDB0-451CA0FD0386Q35043048-D0B04267-1122-4E24-97B5-3447222BE43FQ37115738-03F76434-F063-4CA6-B5B7-6F39D3E927E4Q37369594-45705EB4-6BCA-40DA-9589-F357BFCE43E3Q37391122-22B94B23-60C3-49DB-BCF5-A3DF5068113EQ37392789-40A23C41-4C1A-47C5-A5AD-977AEEDB1714Q37666456-39D126E1-EEB6-4F96-BD4E-C43415C89177Q37690861-6074E13A-C070-469D-8B5A-2739402ECC9FQ37895251-6D95E2D1-EFDC-4AE2-8826-A0987B1287DCQ41392118-21DB2319-DE6A-4B08-AEDD-EF88F8CCA71CQ42615157-76220038-F365-4D82-8AB1-6F8F7A8A71A6Q47102399-2AAC3A30-6C20-4791-86B2-DEEF33315C73
P2860
Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@en
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@nl
type
label
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@en
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@nl
prefLabel
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@en
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@nl
P2093
P2860
P1433
P1476
Standard-dose efavirenz vs. st ...... ients who received rifampicin.
@en
P2093
A Lueangniyomkul
S Chimsuntorn
S Sungkanuparph
W Mankatitham
W Manosuthi
P2860
P304
P356
10.1111/J.1468-1293.2008.00563.X
P577
2008-05-01T00:00:00Z